Better training tools recommended to support using adrenaline auto-injectors

The European Medicines Agency (EMA) has recommended several measures, including the introduction of more effective educational material, to ensure patients and carers use adrenaline auto-injectors successfully. Adrenaline auto-injectors are potentially life-saving treatments for anaphylaxis while the patient waits for emergency medical assistance. The EMA carried out a review of adrenaline auto-injectors following concerns that currently available devices may deliver adrenaline under the skin instead of into a muscle, and this may delay response to treatment. Having assessed all the available data, EMA’s Committee for Medicinal Products for Human Use (CHMP) acknowledged that giving the medicine by injection into the muscle